Header Logo

Connection

JEFFREY ROSEN to Tumor Microenvironment

Back to Details
This is a "connection" page, showing publications JEFFREY ROSEN has written about Tumor Microenvironment.
JEFFREY ROSEN
Connection Strength
2.728
Tumor Microenvironment
  1. Leveraging preclinical models of metastatic breast cancer. Biochim Biophys Acta Rev Cancer. 2024 09; 1879(5):189163.
    View in: PubMed
    Score: 0.627
  2. TIME Is a Great Healer-Targeting Myeloid Cells in the Tumor Immune Microenvironment to Improve Triple-Negative Breast Cancer Outcomes. Cells. 2020 12 23; 10(1).
    View in: PubMed
    Score: 0.489
  3. Alterations in Wnt- and/or STAT3 signaling pathways and the immune microenvironment during metastatic progression. Oncogene. 2019 08; 38(31):5942-5958.
    View in: PubMed
    Score: 0.442
  4. Breast Cancer. Cold Spring Harb Perspect Med. 2024 Aug 01; 14(8).
    View in: PubMed
    Score: 0.157
  5. Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. J Clin Invest. 2023 12 15; 133(24).
    View in: PubMed
    Score: 0.150
  6. Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer. Cancer Immunol Res. 2023 11 01; 11(11):1462-1479.
    View in: PubMed
    Score: 0.149
  7. Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer. Cancer Res. 2022 06 15; 82(12):2281-2297.
    View in: PubMed
    Score: 0.135
  8. Single-Cell Analysis Unveils the Role of the Tumor Immune Microenvironment and Notch Signaling in Dormant Minimal Residual Disease. Cancer Res. 2022 Mar 01; 82(5):885-899.
    View in: PubMed
    Score: 0.133
  9. Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies. Semin Cancer Biol. 2022 07; 82:3-10.
    View in: PubMed
    Score: 0.127
  10. Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nat Cell Biol. 2019 09; 21(9):1113-1126.
    View in: PubMed
    Score: 0.111
  11. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. Cancer Cell. 2015 Feb 09; 27(2):193-210.
    View in: PubMed
    Score: 0.081
  12. The tumor-immune ecosystem in shaping metastasis. Am J Physiol Cell Physiol. 2023 03 01; 324(3):C707-C717.
    View in: PubMed
    Score: 0.035
  13. Metastasis Organotropism: Redefining the Congenial Soil. Dev Cell. 2019 05 06; 49(3):375-391.
    View in: PubMed
    Score: 0.027
  14. Fatal attraction: TICs and MDSCs. Cell Cycle. 2016 10; 15(19):2545-2546.
    View in: PubMed
    Score: 0.023
  15. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016 06; 18(6):632-44.
    View in: PubMed
    Score: 0.022
  16. Predicting drug responsiveness in human cancers using genetically engineered mice. Clin Cancer Res. 2013 Sep 01; 19(17):4889-99.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.